This trial will find the best dose of 3 drugs to treat patients with advanced solid tumors. The drugs will be given together and the side effects will be monitored.
10 Primary · 3 Secondary · Reporting Duration: Every 8 weeks for first 12 months, and every 12 weeks until disease progression; aprroximately 24 months
Experimental Treatment
146 Total Participants · 7 Treatment Groups
Primary Treatment: INCAGN02385 · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: